Agilent, Premier Combine Technologies for Glycomics Research | GenomeWeb

NEW YORK (GenomeWeb) – Certain Agilent Technologies mass spectrometers and liquid chromatography instruments now support Premier Biosoft's SimGlycan glycomics software as part of a deal announced today.

"Agilent and Premier Biosoft are focused on solving the glycan and glycopeptides identification problem in biopharmaceutical analyses," Premier Biosoft CEO Arun Apte said in a statement. "Combining our powerful instruments and software will enable researchers to generate, process, and analyze highly complex data so they can put it to use in drug development."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.